UC San Diego researchers modify remdesivir, creating oral version that can be taken earlier in COVID-19 diagnoses. In cell and animal studies, revised drug proved effective and safe.
News
UC San Diego Students to Compete in Sustainability Decathlon
With the affordable housing crisis reaching a fever pitch in San Diego and the impacts of climate change being felt around the world, a team of students at UC San Diego is putting their skills to work as they de… […]
News
Innovate to Dominate
A new book from Tai Ming Cheung, “Innovate to Dominate: The Rise of the Chinese Techno-Security State,” examines the convergence of national security, innovation and economic development in China, detailing the … […]
News
With Time and Without Masks, COVID-19 Vaccines Wane in Protection
A study measured effectiveness of COVID-19 mRNA vaccines among health workers, most notably during the emergence of delta virus variant and coincident with end of state’s mask mandate, finding protection waned o… […]
